Search Results - boris+chobrutskiy

3 Results Sort By:
Cancer Patients with an Anti-Epstein-Barr Virus (EBV) Immune Response Show Improved Outcomes
­Advantages: Cancers with an adaptive immune response (T cell and antibody response) to EBV correlate with better outcomes: tested in ovarian cancer, stomach adenocarcinoma, Burkitt lymphoma, and diffused large B cell lymphoma Could be developed into a potential predictive biomarker that utilizes antibody and/or T cell receptor CDR3 sequencing...
Published: 11/7/2024   |   Inventor(s): George Blanck, Rahul Jain, Taha Huda, Srijit Paul, Boris Chobrutskiy, Andrea Chobrutskiy, Nandini Goel, Madeline Baker, Joanna Song, Veda Vangala, Michael Diaz
Keywords(s): Cancer Diagnostics
Category(s): Technology Classifications > Cancer > Cancer Diagnostics, Technology Classifications > Medical > Medical Diagnostics
Tau as a Biomarker for Low Grade Glioma (LLG) and Neuroblastoma Patients
Competitive Advantages A prognostic biomarker for LGG and neuroblastoma May be used to develop new treatments May increase patient survivability Summary The association of the MAPT gene (microtubule-associated protein Tau), which encodes Tau protein, with various tauopathies and other neurological disorders has long been established. However,...
Published: 9/9/2024   |   Inventor(s): George Blanck, Saif Zaman, Boris Chobrutskiy
Keywords(s):  
Category(s): Technology Classifications > Cancer, Technology Classifications > Medical > Oncology
Immune Receptor Mutant Peptide Complementarity Scoring for Therapy Design and Prognosis
Competitive Advantages A prognostic genomic-based method Improved survival prediction accuracies Improved immunotherapy effectiveness predictions Measures tumor immune activity Summary USF researchers have developed a genomics-based method to provide prognoses based on tumor immune activity. Also provided are indications for components for...
Published: 9/30/2022   |   Inventor(s): George Blanck, Boris Chobrutskiy
Keywords(s):  
Category(s): Technology Classifications > Cancer > Cancer Diagnostics, Technology Classifications > Cancer